Yeji
NDA/BLA filedconf 0.95

relacorilant — NDA/BLA filed

$CORT · CORCEPT THERAPEUTICS INC · hypertension secondary to hypercortisolism
Event date
September 10, 2025
269 days ago
Sponsor runway
5+ yrs
$338.2M liquid

Evidence

the U.S. Food and Drug Administration (FDA) has accepted Corcept's New Drug Application (NDA) for relacorilant as a treatment for patients with platinum-resistant ovarian cancer.
Source: Press release · 2025-09-10View press release ↗

Comparable historical nda/bla fileds· last 5 years · same indication

TickerDrugDateOutcome
$CORTrelacorilant2025-03-03unknown

Recent insider activity· ±90 days

8 insiders · 0 buys · 58 sells
Tax10b5-1
2025-12-02
Maduck Sean
See Remarks
135 @ $79.78$11K
Gift10b5-1
2025-12-02
Guyer William
Chief Development Officer
787 @
Other10b5-1
2025-12-02
Guyer William
Chief Development Officer
787 @
Exercise10b5-1
2025-12-02
Guyer William
Chief Development Officer
20,000 @ $21.65$433K
Tax10b5-1
2025-12-02
Lyon Joseph Douglas
See Remarks
110 @ $79.78$9K
Tax
2025-12-02
Mokari Atabak
Chief Financial Officer
118 @ $79.78$9K
Sell10b5-1
2025-12-02
Guyer William
Chief Development Officer
19,360 @ $80.05$1.55M
Tax
2025-12-02
Robb Gary Charles
Chief Business Officer
148 @ $79.78$12K
Sell10b5-1
2025-12-02
Guyer William
Chief Development Officer
640 @ $80.88$52K
Sell10b5-1
2025-12-01
BELANOFF JOSEPH K
Chief Executive Officer
40,000 @ $79.77$3.19M
Sell10b5-1
2025-12-01
Lyon Joseph Douglas
See Remarks
5,000 @ $79.53$398K
Grant10b5-1
2025-12-01
Lyon Joseph Douglas
See Remarks
178 @ $79.78$14K
Grant10b5-1
2025-12-01
Guyer William
Chief Development Officer
224 @ $79.78$18K
Exercise10b5-1
2025-12-01
Lyon Joseph Douglas
See Remarks
5,000 @ $13.56$68K
Grant
2025-12-01
Mokari Atabak
Chief Financial Officer
178 @ $79.78$14K
Grant10b5-1
2025-12-01
Maduck Sean
See Remarks
205 @ $79.78$16K
Sell10b5-1
2025-12-01
Maduck Sean
See Remarks
20,000 @ $79.52$1.59M
Exercise10b5-1
2025-12-01
Maduck Sean
See Remarks
20,000 @ $8.27$165K
Grant
2025-12-01
Robb Gary Charles
Chief Business Officer
224 @ $79.78$18K
Sell
2025-11-25
Guyer William
Chief Development Officer
4,500 @ $80.90$364K
Sell10b5-1
2025-11-05
Guyer William
Chief Development Officer
13,164 @ $75.64$996K
Exercise10b5-1
2025-11-05
Guyer William
Chief Development Officer
20,000 @ $21.65$433K
Sell10b5-1
2025-11-05
Guyer William
Chief Development Officer
6,536 @ $74.75$489K
Sell10b5-1
2025-11-05
Guyer William
Chief Development Officer
300 @ $76.28$23K
Sell10b5-1
2025-11-05
BELANOFF JOSEPH K
Chief Executive Officer
14,355 @ $74.20$1.07M
Sell10b5-1
2025-11-05
BELANOFF JOSEPH K
Chief Executive Officer
10,837 @ $75.14$814K
Sell10b5-1
2025-11-05
BELANOFF JOSEPH K
Chief Executive Officer
3,590 @ $75.98$273K
Sell10b5-1
2025-11-03
Maduck Sean
See Remarks
20,000 @ $73.99$1.48M
Exercise10b5-1
2025-11-03
Lyon Joseph Douglas
See Remarks
5,000 @ $13.56$68K
Sell10b5-1
2025-11-03
BELANOFF JOSEPH K
Chief Executive Officer
11,218 @ $74.08$831K
Sell10b5-1
2025-11-03
Lyon Joseph Douglas
See Remarks
5,000 @ $73.65$368K
Exercise10b5-1
2025-11-03
Maduck Sean
See Remarks
20,000 @ $8.27$165K
Exercise10b5-1
2025-10-10
Swisher Daniel N JR
Director
2,200 @ $14.08$31K
Sell10b5-1
2025-10-10
Swisher Daniel N JR
Director
2,200 @ $87.54$193K
Sell10b5-1
2025-10-07
Guyer William
Chief Development Officer
20,000 @ $89.94$1.80M
Exercise10b5-1
2025-10-07
Guyer William
Chief Development Officer
20,000 @ $21.65$433K
Sell10b5-1
2025-10-01
Maduck Sean
See Remarks
959 @ $83.73$80K
Sell10b5-1
2025-10-01
Maduck Sean
See Remarks
16,394 @ $85.06$1.39M
Sell10b5-1
2025-10-01
Maduck Sean
See Remarks
2,647 @ $85.58$227K
Sell10b5-1
2025-10-01
Lyon Joseph Douglas
See Remarks
600 @ $85.39$51K
Sell10b5-1
2025-10-01
BELANOFF JOSEPH K
Chief Executive Officer
5,616 @ $84.29$473K
Sell10b5-1
2025-10-01
BELANOFF JOSEPH K
Chief Executive Officer
31,190 @ $85.16$2.66M
Sell10b5-1
2025-10-01
BELANOFF JOSEPH K
Chief Executive Officer
3,194 @ $85.67$274K
Exercise10b5-1
2025-10-01
Lyon Joseph Douglas
See Remarks
5,000 @ $13.56$68K
Sell10b5-1
2025-10-01
Lyon Joseph Douglas
See Remarks
927 @ $83.71$78K
Sell10b5-1
2025-10-01
Lyon Joseph Douglas
See Remarks
3,473 @ $84.92$295K
Exercise10b5-1
2025-10-01
Maduck Sean
See Remarks
1,986 @ $5.05$10K
Exercise10b5-1
2025-10-01
Maduck Sean
See Remarks
18,014 @ $8.27$149K
Gift
2025-09-19
Guyer William
Chief Development Officer
200 @
Gift
2025-09-10
Cannon Gillian
Director
7,393 @
+ 67 more